Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain
· Delayed Price · Currency is EUR 80.85
+0.15 (0.19%)
At close: Mar 6, 2026
BME:ROVI Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 140.44 | 136.88 | 170.34 | 199.67 | 153.08 | Upgrade
|
| Depreciation & Amortization | 28.76 | 26.92 | 23.44 | 21.84 | 20.3 | Upgrade
|
| Other Amortization | 1.62 | 1.09 | 0.9 | 1.03 | 1.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 4.39 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.51 | -0.08 | 0.22 | -1.83 | -1.16 | Upgrade
|
| Loss (Gain) on Equity Investments | -0.06 | 0.14 | 0.13 | -0.2 | -0.18 | Upgrade
|
| Stock-Based Compensation | - | - | - | - | 1.4 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.31 | -7.97 | -0.04 | 0.04 | -0.27 | Upgrade
|
| Other Operating Activities | 11.55 | -32.06 | -47.28 | 74.03 | 39.24 | Upgrade
|
| Change in Accounts Receivable | -30.19 | 13.41 | 19.47 | -26.82 | -74.19 | Upgrade
|
| Change in Inventory | 42.99 | 11.87 | -29.29 | -71.59 | -23.43 | Upgrade
|
| Change in Accounts Payable | -7.75 | -16.36 | -23.92 | 41.67 | 35.36 | Upgrade
|
| Change in Other Net Operating Assets | -0.5 | 0.04 | -0.7 | -0.23 | -1.78 | Upgrade
|
| Operating Cash Flow | 187.08 | 138.28 | 113.25 | 237.6 | 149.44 | Upgrade
|
| Operating Cash Flow Growth | 35.29% | 22.10% | -52.34% | 58.99% | 218.80% | Upgrade
|
| Capital Expenditures | -65.21 | -59.12 | -53.79 | -50.72 | -40.22 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | 0.04 | 0.38 | 0.08 | 0.03 | Upgrade
|
| Sale (Purchase) of Intangibles | -2.6 | -3.1 | -1.39 | -0.67 | -0.72 | Upgrade
|
| Investment in Securities | -3.46 | -19.01 | 1.29 | -5.85 | - | Upgrade
|
| Other Investing Activities | 2.66 | 0.13 | 1.49 | 0.01 | 0.07 | Upgrade
|
| Investing Cash Flow | -68.48 | -81.06 | -52.03 | -57.15 | -40.84 | Upgrade
|
| Long-Term Debt Issued | 47.61 | 96.95 | 0.73 | 1.4 | 1.34 | Upgrade
|
| Long-Term Debt Repaid | -46.79 | -51.71 | -13.65 | -6.77 | -6.19 | Upgrade
|
| Net Debt Issued (Repaid) | 0.82 | 45.24 | -12.92 | -5.37 | -4.85 | Upgrade
|
| Issuance of Common Stock | 54.85 | 41.92 | 52.64 | 77.77 | 42.33 | Upgrade
|
| Repurchase of Common Stock | -54.86 | -89.71 | -133.9 | -177.01 | -78.79 | Upgrade
|
| Common Dividends Paid | -47.83 | -56.45 | -69.05 | -51.01 | -21.13 | Upgrade
|
| Other Financing Activities | -0.79 | 3.64 | 2.39 | 1.08 | -0.29 | Upgrade
|
| Financing Cash Flow | -47.81 | -55.36 | -160.84 | -154.54 | -62.73 | Upgrade
|
| Net Cash Flow | 70.79 | 1.86 | -99.62 | 25.91 | 45.87 | Upgrade
|
| Free Cash Flow | 121.87 | 79.16 | 59.45 | 186.88 | 109.22 | Upgrade
|
| Free Cash Flow Growth | 53.95% | 33.15% | -68.19% | 71.10% | 1348.77% | Upgrade
|
| Free Cash Flow Margin | 16.39% | 10.37% | 7.17% | 22.86% | 16.84% | Upgrade
|
| Free Cash Flow Per Share | 2.38 | 1.55 | 1.12 | 3.50 | 1.97 | Upgrade
|
| Cash Interest Paid | 2.3 | 1.77 | 0.39 | 0.29 | 0.29 | Upgrade
|
| Cash Income Tax Paid | 41.93 | 44.23 | 40.86 | 43.89 | 23.86 | Upgrade
|
| Levered Free Cash Flow | 82.3 | 44.85 | 25.36 | 135.92 | 66.2 | Upgrade
|
| Unlevered Free Cash Flow | 83.9 | 46.09 | 25.95 | 136.45 | 66.76 | Upgrade
|
| Change in Working Capital | 4.55 | 8.96 | -34.45 | -56.97 | -64.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.